Prabhat Singh Malik

8PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceMajor global burdens of diseaseCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2025
Primary de novo Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature.

Aruna Nambirajan, Amber Rathor, Hemavathi Baskarane

|Mar 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India.

Sneh Bhargave, Vinod Sharma, Babita Kataria

|Feb 27, 2024
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.

Akhil Santhosh, Atul Sharma, Sameer Bakhshi

|Feb 22, 2024
SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.

Chitrakshi Nagpal, Atul Sharma, Sameer Bakhshi

|Jun 01, 2023
A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG).

S Verma, S Chitikela, V Singh

|Feb 22, 2023
Severity and mortality prediction models to triage Indian COVID-19 patients.

Samarth Bhatia, Yukti Makhija, Sneha Jayaswal

Pageof 2

Frequent Collaborators

4 joint publications

Sachin Khurana

3 joint publications

Atul Batra

3 joint publications

Raja Pramanik

3 joint publications

Sameer Bakhshi